Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on The Emergence of Omicron: A Variant of Concern - By Dr. Ashwini.
Dr. Ashwini discusses the emergence of Omicron, a variant of concern of the SARS-CoV-2 virus, which was first identified in South Africa in late 2021. Omicron quickly gained global attention due to its unprecedented number of mutations in the spike protein, raising concerns about increased transmissibility and potential resistance to existing vaccines and treatments.
Omicron's rapid spread has been attributed to its ability to evade immunity from previous infections and vaccinations more effectively than earlier variants. Dr. Ashwini highlights that, despite its higher transmissibility, preliminary data suggested that Omicron might cause less severe disease compared to the Delta variant. However, the sheer volume of cases posed significant challenges to healthcare systems worldwide, leading to increased hospitalizations and strain on medical resources.
To combat Omicron, Dr. Ashwini emphasizes the importance of booster vaccination campaigns, which have shown to enhance protection against this variant. Additionally, ongoing research and adaptation of COVID-19 treatments and preventive measures are crucial in addressing the evolving threat posed by Omicron and future variants. Public health strategies, including widespread testing, genomic surveillance, and reinforcing public health measures, remain essential in mitigating the impact of Omicron.
Therefore, get an overall knowledge of Th
See More Webinars @ Hidoc Webinars
1.
Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity
2.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
5.
Microplastics can cause malignant changes in lung cells
1.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
4.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
5.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation